loading

Finanzdaten der Forte Biosciences Inc-Aktie (FBRX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- 1.314 - -
Operating Expenses
28.19%
11.58
16.12 7.351 8.629 12.82
Operating Income/Loss
28.19%
-11.58
-16.12 -7.351 -8.629 -12.82
Income/Loss From Continuing Operations Before Tax
28.15%
-11.25
-15.66 -7.155 -8.392 -12.51
Income/Loss From Continuing Operations After Tax
28.15%
-11.25
-15.66 -7.155 -8.392 -12.51
Net Income/Loss
28.15%
-11.25
-15.66 -7.155 -8.392 -12.51
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Earnings Per Share
29.93%
-0.96
-1.37 3.18 -4.54 -0.27
Diluted Earnings Per Share
29.93%
-0.96
-1.37 3.18 -4.54 -0.27
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$35.67
price down icon 1.07%
$86.06
price down icon 0.72%
$27.40
price down icon 0.62%
$108.26
price down icon 2.97%
$146.01
price up icon 0.58%
biotechnology ONC
$345.40
price up icon 1.04%
Kapitalisierung:     |  Volumen (24h):